The disclosure relates to chemokine receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for managing chemokine related conditions, typically prevention or treatment of viral infections such as HIV or for managing cancer.
本公开涉及
趋化因子受体调节剂及其相关用途。在某些实施例中,本公开涉及包括本公开披露的化合物或其药用盐或前药的制药组合物。在某些实施例中,本公开披露的组合物用于管理与
趋化因子相关的疾病,通常是预防或治疗病毒感染如HIV或管理癌症。